Ovarian Malignancy Screening by POC Test

XEMAtest Ovascreen

XEMAtest Ovascreen is a rapid immunochromatographic test for simultaneous determination of CA125 and HE4 antigens in serum, plasma or capillary blood. A combined determination of HE4 and CA125 allows to increase efficiency of ovarian cancer diagnostics during screening.

XEMAtest Ovascreen is available as a visual version and soon as magnetic version for a specific reader manufactured by Mangnasence Technologies, which also provides quantitation and built- in calculation for risk of ovarian malignancy.

Ready visual test and magnetic test prototype together with the reader can be seen at our stand at MEDICA.